DNA Repair Drugs Market Connected with Market Growth fueled by Rising Prevalence of Cancer
Market
Overview:
DNA repair
drugs play a vital role in repairing damaged DNA during cancer treatment. They
repair damaged DNA caused by radiation or chemotherapy treatment and help target
and destroy cancer cells more effectively with reduced side effects. DNA repair
drugs aid in repair of single and double strand DNA breaks that occur during
cancer treatment to enhance efficacy of radiation and chemotherapy.
Market key trends:
One of the key factors driving growth of the DNA repair drugs market is
increasing prevalence of cancer worldwide. According to the World Health
Organization (WHO), cancer burden rose to 18.1 million new cases and 9.6
million deaths in 2018 globally. Improper DNA repair of radiation and
chemotherapy treatment induced DNA damage in cancer cells leads to recurrence
of cancer. DNA repair drugs helps repair these damages in DNA aiding longer
remission duration and improved survival rates. They promote restoration of DNA
integrity and cellular repair capacity enabling safe and efficient
administration of higher curative radiation and chemotherapy doses for better
treatment outcomes.
Market
Dynamics:
The DNA
Repair Drugs Market Growth is witnessing high growth owing to the
rising prevalence of various types of cancer globally. According to the World
Health Organization, cancer is a leading cause of death worldwide, accounting
for nearly 10 million deaths in 2020. The increasing research and development
activities in the area of DNA damage repair pathways have led to a rise in the
pipeline drugs for different cancer types. Further, the approval and launch of
new DNA repair drugs to treat cancer is also boosting the market growth. For
instance, in January 2022, the U.S FDA granted accelerated approval to Repare
Therapeutics' HER2-directed DNA repair inhibitor camonsertib for recurrent or
metastatic HER2-positive breast cancer patients.
SWOT Analysis
Strength: DNA repair drugs have shown promising results in clinical trials. The
repair mechanisms have broad applications across several cancer types.
Researchers are continuously working to develop newer targeted molecules.
Weakness: DNA repair is a complex process involving multiple pathways.
Targeting specific defects requires thorough understanding of the underlying
biology. High costs are involved in drug development and clinical trials.
Opportunity: With advancing research, more cancer driver mutations are being
identified. This will expand the scope of personalized targeted therapies.
Collaboration between pharmaceutical companies and research institutes can help
expedite the drug development process.
Threats: Competing drug classes like immunotherapies are becoming popular
treatment options. Financial pressure during drug development may lead to
project delays or discontinuation. Stringent regulations surrounding clinical
trials also pose challenges.
Key Takeaways
The global DNA repair drugs market is expected to witness high growth,
exhibiting CAGR of 32.4% over the
forecast period, due to increasing incidence of cancer worldwide. Targeted
drugs that inhibit specific DNA repair pathways have shown promising results with
improved efficacy and lesser side effects compared to traditional chemotherapy.
Regional analysis
North America currently dominates the global market due to advanced research
facilities and increasing adoption of personalized medicines in the region.
However, Asia Pacific is expected to grow at a high CAGR during the forecast
period due to rising healthcare spending, growing cancer burden and expanding
pharmaceutical industry in the region.
Key players
Key players operating in the DNA repair drugs market are AstraZeneca Plc.,
Johnson & Johnson, GlaxoSmithKline plc., Pfizer, Inc., Clovis Oncology
Inc., AbbVie Inc., Bristol - Myers Squibb, Merck KGaA, Genentech, Inc., Repare
Therapeutics Inc., Karyopharm Therapeutics Inc., Ono Pharmaceutical Co., LTD.,
and Jiangsu Hengrui Medicine Co., Ltd. The market is mostly consolidated with
these global players having majority share.
Read More:
https://www.dailyprbulletin.com/dna-repair-drugs-market-connected-with-market-growth/
Comments
Post a Comment